
UAE approves Russia-made Sputnik V Covid-19 vaccine
(adsbygoogle = window.adsbygoogle || []).push({}); The Russian Direct Investment Fund (RDIF) said that the Russian Sputnik V Covid-19 vaccine has been authorized for use by the UAE Ministry of Health More...

Dr. Reddy’s reports success for Russian Covid-19 vaccine Sputnik V
Indian pharma company Dr. Reddy’s Laboratories announced that Sputnik V, a registered Covid-19 vaccine in Russia, has succeeded in a phase 2 trial in India by meeting the primary endpoint of safety. An independent More...

Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech
Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company BioNTech. The Swiss pharma regulator said that More...

Lilly to launch pragmatic study of Covid-19 drug candidate bamlanivimab in New Mexico
Eli Lilly and Company (Lilly) has revealed plans to launch a new pragmatic study of bamlanivimab (LY-CoV555) in high-risk patients with Covid-19, in partnership with major local institutions in New Mexico. The US More...

US FDA authorizes Moderna Covid-19 vaccine mRNA-1273
Moderna Covid-19 vaccine : The US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for mRNA-1273, the messenger RNA (mRNA) Covid-19 vaccine candidate of Moderna. The FDA authorization More...

Pfizer and BioNTech secure FDA EUA for BNT162b2 Covid-19 vaccine
BNT162b2 FDA EUA : Pfizer and BioNTech have been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for BNT162b2, their Covid-19 mRNA vaccine. BNT162b2 has been authorized by More...

Pfizer, BioNTech get Canadian approval for BNT162b2 Covid-19 vaccine
US pharma giant Pfizer and German biotech company BioNTech have bagged Health Canada approval for their BNT162b2 Covid-19 vaccine. The BNT162b2 vaccine has been authorized to be used in Canada under the regulator’s More...

BNT162b2 Covid-19 vaccine candidate more than 90% effective in phase 3 trial, say Pfizer and BioNTech
Pfizer and BioNTech announced that the BNT162b2 mRNA-based vaccine candidate has been shown to be more than 90% effective in the prevention of Covid-19 in participants of a phase 3 trial who were not previously More...

UK pub operator Mitchells & Butlers secures £100m CLBILS loan
UK pub operator Mitchells & Butlers has been granted £100 million of additional funding from HSBC UK and Santander UK as part of the UK government’s Coronavirus Large Business Interruption Loan Scheme More...

COVID-19 forces Texas Capital, Independent Bank to call off $5.5bn merger
The prevailing coronavirus pandemic has forced US bank holding companies Texas Capital Bancshares and Independent Bank Group to terminate their previously announced all-stock merger of equals worth $5.5 billion. Both More...